Adiponectin increases insulin sensitivity, lowers the level of circulating lipids and protects against atherosclerosis [56, 57], and low levels of it are found in people with obesity, insulin resistance and type II diabetes [58]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.